Sociodemographic and clinical risk characteristics of patients with prostate cancer within the Veterans Affairs health care system: Data from CaPSURE

Journal of Urology

Volumn 170, Issue 3, 2003, Pages 905-908

  Cooperberg, Matthew R ^a   Lubeck, Deborah P ^a   Penson, David F ^c,d   Mehta, Shilpa S ^e   Carroll, Peter R ^a   Kane, Christopher J ^a,b,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e TAP PHARMACEUTICAL PRODUCTS INC   (United States)

^f Box 0738 ^*  (United States)

Author keywords

Ethnicity; Prostate; Prostatic neoplasms; United States Department of Veterans Affairs

Indexed keywords

ANTIANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER HORMONE THERAPY; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; COMORBIDITY; DATA BASE; DEMOGRAPHY; EDUCATION; ETHNOLOGY; HEALTH CARE SYSTEM; HUMAN; HUMAN TISSUE; INCOME; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; PROSTATE CANCER; SOLDIER; UNITED STATES; VALIDATION PROCESS;

EID: 0043239175     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000081200.63275.0b     Document Type: Article

References (15)

1. Feussner, J. R.: Clinical research in the Department of Veterans Affairs: using research to improve patient outcomes. J Investig Med, 46: 264, 1998
2. Hrushesky, W. J.: The Department of Veterans Affairs' unique clinical cancer research effort. Cancer, suppl., 74: 2701, 1994
3. Blackard, C. E.: The Veterans' Administration Cooperative Urological Research Group studies of carcinoma of the prostate: a review. Cancer Chemother Rep, 59: 225, 1975
4. Wilt, T. J. and Brawer, M. K.: The Prostate Cancer Intervention Versus Observation Trial: a randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer. J Urol, 152: 1910, 1994
5. Lubeck, D. P., Litwin, M. S., Henning, J. M., Stier, D. M., Mazonson, P., Fisk, R. et al: The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology, 48: 773, 1996
6. D'Amico, A. V., Whittington, R., Malkowicz, S. B., Schultz, D., Blank, K., Broderick, G. A. et al: Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA, 280: 969, 1998
7. Charlson, M. E., Pompei, P., Ales, K. L. and MacKenzie, C. R.: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis, 40: 373, 1987
8. Tarman, G. J., Kane, C. J., Moul, J. W., Thrasher, J. B., Foley, J. P., Wilhite, D. et al: Impact of socioeconomic status and race on clinical parameters of patients undergoing radical prostatectomy in an equal access health care system. Urology, 56: 1016, 2000
9. van der Gulden, J. W., Kolk, J. J. and Verbeek, A. L.: Socioeconomic status, urbanization grade, and prostate cancer. Prostate, 25: 59, 1994
10. Stamey, T. A., McNeal, J. E., Yemoto, C. M., Sigal, B. M. and Johnstone, I. M.: Biological determinants of cancer progression in men with prostate cancer. JAMA, 281: 1395, 1999
11. Sartor, O. and Powell, I. J.: Race and risk. In: Prostate Cancer: Principles and Practice. Edited by P. W. Kantoff, P. R. Carroll and A. V. D'Amico. Philadelphia: Lippincott Williams & Wilkins Co., pp. 162-174, 2002
12. Amling, C. L., Kane, C. J., Riffenburgh, R. H., Ward, J. F., Roberts, J. L., Lance, R. S. et al: Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy. Urology, 58: 723, 2001
13. Levi, F. and La Vecchia, C.: Tobacco smoking and prostate cancer: time for an appraisal. Ann Oncol, 12: 733, 2001
14. Kane, C. J., Lubeck, D. P., Spitalny, G. M., Knight, S., Grossfeld, G. D., Mehta, S. et al: The impact of patient educational level on selection of treatment for newly diagnosed prostate cancer. J Urol, suppl., 167: 69, abstract 272, 2002
15. Freedland, S. J., Amling, C. L., Dorey, F., Kane, C. J., Presti, J. C., Jr., Terris, M. K. et al: Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Urology, 60: 670, 2002